Year archive

RemeGen Co., Ltd. — 2026 filings

All 53 regulatory filings released by RemeGen Co., Ltd. (9995) in 2026, sourced directly from the official regulator.

53 Filings

2026 Period

2026 filings (53)

Filing	Released	Lang
H股公告 Regulatory Filings	2026-05-26	Chinese
H股公告 Regulatory Filings	2026-05-20	Chinese
荣昌生物关于召开2025年年度股东会的通知 Proxy Solicitation & Information Statement	2026-05-20	Chinese
H股公告 Regulatory Filings	2026-05-19	Chinese
H股公告 Regulatory Filings	2026-05-19	Chinese
荣昌生物关于部分募投项目子项目变更及金额调整的公告 Capital/Financing Update	2026-05-18	Chinese
荣昌生物公司章程 Governance Information	2026-05-18	Chinese
独立董事候选人声明与承诺（黄国滨） Board/Management Information	2026-05-18	Chinese
独立董事提名人声明与承诺（黄国滨） Proxy Solicitation & Information Statement	2026-05-18	Chinese
荣昌生物第二届董事会第三十八次会议决议公告 Board/Management Information	2026-05-18	Chinese
独立董事提名人声明与承诺（陈云金） Board/Management Information	2026-05-18	Chinese
荣昌生物关于公司董事会换届选举的公告 Board/Management Information	2026-05-18	Chinese
独立董事候选人声明与承诺（陈云金） Regulatory Filings	2026-05-18	Chinese
独立董事候选人声明与承诺（宋希亮） Proxy Solicitation & Information Statement	2026-05-18	Chinese
荣昌生物关于变更注册资本暨修订《公司章程》、修订及制定部分内部管理制度的公告 Share Issue/Capital Change	2026-05-18	Chinese
独立董事提名人声明与承诺（宋希亮） Proxy Solicitation & Information Statement	2026-05-18	Chinese
荣昌生物董事会提名委员会关于第三届董事会独立董事候选人的审核意见 Board/Management Information	2026-05-18	Chinese
荣昌生物信息披露管理制度 Governance Information	2026-05-18	Chinese
华泰联合证券有限责任公司关于荣昌生物制药（烟台）股份有限公司部分募投项目子项目变更及金额调整的核查意见 Regulatory Filings	2026-05-18	Chinese
荣昌生物董事、高级管理人员薪酬管理制度 Governance Information	2026-05-18	Chinese
荣昌生物董事会议事规则 Governance Information	2026-05-18	Chinese
H股公告 Regulatory Filings	2026-05-15	Chinese
荣昌生物制药（烟台）股份有限公司关于参加“对话成长”2025年度暨2026年一季度集体业绩说明会的公告 Investor Presentation	2026-05-06	Chinese
DATE OF BOARD MEETING Report Publication Announcement	2026-04-16	English
VOLUNTARY ANNOUNCEMENT - Receipt of US$650 Million Upfront Payment from AbbVie under the Exclusive License Agreement for RC148 Regulatory Filings	2026-04-15	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-14	English
VOLUNTARY ANNOUNCEMENT - Approval of the New Drug Application for Disitamab Vedotin for the Indication of HER2-Expressing Urothelial Carcinoma Regulatory Filings	2026-04-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-09	English
Voluntary Announcement - NMPA APPROVES THE CLINICAL TRIAL OF BISPECIFIC ANTIBODY-DRUG CONJUGATE (BISPECIFIC ADC) RC288 FOR INJECTION Regulatory Filings	2026-04-01	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Report Publication Announcement	2026-03-29	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 Annual Report FY 2025	2026-03-27	English
VOLUNTARY ANNOUNCEMENT - Approval of the New Drug Application for Disitamab Vedotin for the Indication of HER2-Low Breast Cancer with Liver Metastases Regulatory Filings	2026-03-23	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-04	English
INSIDE INFORMATION - 2025 ANNUAL RESULTS UPDATE ANNOUNCEMENT Earnings Release FY 2025	2026-02-27	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2026-02-27	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-05	English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-02	English
INSIDE INFORMATION - ESTIMATED 2025 ANNUAL RESULTS Earnings Release FY 2025	2026-01-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2026-01-21	English
Next Day Disclosure Return Transaction in Own Shares	2026-01-21	English
ANNOUNCEMENT ON THE FIRST SHARE REPURCHASE AND THE COMPLETION OF THE SHARE REPURCHASE PLAN Transaction in Own Shares	2026-01-21	English
ANNOUNCEMENT ON THE ADJUSTMENT TO THE UPPER LIMIT OF THE PRICE OF A SHARE REPURCHASE Transaction in Own Shares	2026-01-15	English
INSIDE INFORMATION - Announcement on Signing a License Agreement with AbbVie Capital/Financing Update	2026-01-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Regulatory Filings	2026-01-07	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2026-01-05	English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-05	English

Filings by year

2026 53 filings
2025 182 filings
2024 180 filings
2023 201 filings
2022 183 filings
2021 148 filings
2020 95 filings
2019 45 filings
2018 56 filings
2017 53 filings
2016 41 filings
2015 35 filings
2014 47 filings
2013 43 filings
2012 54 filings
2011 40 filings
2010 43 filings
2009 47 filings
2008 24 filings
2007 32 filings
2006 16 filings
2005 6 filings